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Purpose: Medication adherence is an essential part of the management and control of high blood pres-
sure (HBP). Although the Hill-Bone Medication Adherence (HBMA) scale is one of the most frequently
used instruments for measuring HBP medication adherence, the psychometric properties of the scale
have never been tested among Korean Americans, a population that experiences a disproportionately
high prevalence of HBP. Therefore, the objective of this study is to validate a Korean version of the HBMA
subscale (HBMA-K).
Method: We used two, independent samples of Korean Americans (KAs) (combined n ¼ 525) who
participated in community-based intervention trials for HBP control. To develop the HBMA-K, the
original scale was translated into Korean and then back translated into English. Reliability was assessed
by calculating the Cronbach’s alpha. Exploratory factor analysis (EFA) was done to assess construct
validity. We also calculated the Pearson’s correlation coefﬁcients between the scale and theoretically
driven variables such as blood pressure, knowledge, and HBP belief to test concurrent validity.
Results: The EFA revealed a one-factor solution with eight items, explaining 35.4% of the variance.
Cronbach’s alpha was .80. The 8-item HBMA-K scale was signiﬁcantly associated with systolic blood
pressure (BP) (r ¼ .18, p < .01), diastolic BP (r ¼ .24, p < .01), HBP knowledge (r ¼ .13, p < .01), and HBP
belief score (r ¼ .18, p < .05).
Conclusions: The 8-item HBMA-K scale is a valid and reliable instrument for measuring medication
adherence among KAs with HBP. It can be easily administered at community and clinical settings to
screen hypertensive patients with low medication adherence.
Copyright  2011, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Despite overwhelming evidence for the effectiveness of phar-
macological interventions in reducing high blood pressure (HBP)
and relevant cardiovascular disease (CVD) risk factors (Dragomir
et al., 2010; Taira et al., 2007), many hypertensive patients report
difﬁculty adhering to their recommended antihypertensive medi-
cation regimen. Poor adherence to antihypertensive regimens
results in poor clinical outcomes, as well as increased hospitaliza-
tions and health care costs (Dragomir et al.; Sokol, McGuigan,
Verbrugge, & Epstein, 2005), with reports estimating that poor
medication adherence accounts for as much as $300 billion in, Eulji University School of
Gyeonggi-Do 461-713, Korea.
rean Society of Nursing Science. Puunnecessary health care expenses each year (Vlasnik, Aliotta, &
Delor, 2005).
Available epidemiological studies indicate that Korean Ameri-
cans (KAs) have a higher prevalence of HBP compared to the
general population in the United States (32% vs. 29.6%), as well as
their counterparts in Korea (21.8% of men, 19.4% of women)
(Kearney, Whelton, Reynolds, Whelton, & He, 2004; M. T. Kim, K. B.
Kim, Juon, & Hill, 2000; Ong, Cheung, Man, Lau, & Lam, 2007).
Previous studies have reported poor medication adherence among
KAs notwithstanding their high prevalence of HBP. In particular,
approximately 60% of KAs with HBP report that they are not
adherent to their medication regimen (E. Y. Kim et al., 2007;
M. T. Kim, Juon, Hill, Post, & Kim, 2001; M. T. Kim, Kim, et al., 2000).
Language barriers, cultural differences, less accessibility to the US
health care system and lack of health insurance partly explains the
lowmedication adherence rates among KAs. Additionally, poor HBP
knowledge and incongruent health beliefs are associated withblished by Elsevier. All rights reserved.
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(Doggrell, 2010; Gohar, Greenﬁeld, Beevers, Lip, & Jolly, 2008;
Kettani et al., 2009; E. Y. Kim et al., 2007; M. T. Kim et al., 2008;
Krousel-Wood, Muntner, Jannu, Desalvo, & Re, 2005; Morisky,
Ang, Krousel-Wood, &Ward, 2008; Ross, Walker, & MacLeod, 2004;
Vlasnik et al., 2005). These factors undoubtedly also affect KAs, and
cumulatively contribute to the higher rates of uncontrolled HBP in
this population (M. T. Kim, Kim, et al., 2000).
Several medication adherence scales such as the Hill-Bone Scale,
Morisky Medication Adherence Scale, and Brief Medication Ques-
tionnaire have been used in the literature. The Hill-Bone Scale
(M. T. Kim, Hill, Bone, & Levine, 2000) is one of themost broadly used
adherence scales. It is a 14-item scale that has been validated in
various settings and populations including African-Americans, Ger-
mans and Turkish (Karademir, Koseoglu, Vatansevor, & Akker, 2009;
M. T. Kim,Hill, et al., 2000; Koschack,Marx, Schnakenberg, Kochen, &
Himmel, 2009; Lambert et al., 2006). The Morisky Medication
Adherence scale consists of 4 itemswithyes or no responses. The low
number of items on the scale often translates into total scores with
a skewed distribution and low reliability, resulting in serious limi-
tations (Morisky et al., 2008). The Brief Medication Questionnaire
(Svarstad, Chewning, Sleath, & Claesson, 1999) has nine items with
three subscales:the regimen screen, belief screen, and recall screen,
which are used according to the reported type of medication non-
adherence (repeat vs. sporadic nonadherence). While the Brief
MedicationQuestionnaire appears to be a useful clinical tool because
it focuses on identifying speciﬁc medication barriers, evidence
supporting the validity of this tool is not sound. The original vali-
dation study only used 20 participants, precluding the ability to
adequately assess the psychometric properties of the tool. Addi-
tionally, neither the Brief Medication Questionnaire nor theMorisky
Scale has been adequately validated in the KA population.
In light of these considerations, the purpose of this study was to
assess the validity and reliability of the Korean version of Hill-Bone
Medication Adherence scale (HBMA-K). Once the reliability and
validity of the HBMA-K is established, it will then be suitable for use
among hypertensive KAs in both the clinical and community
settings to assess medication adherence. Ultimately, we hope this
assessment tool will aid in the reduction of cardiovascular health
disparities that currently exists among KAs.
Methods
Study design and sample
Data for this analysis were taken from two community-based
HBP intervention trials that targeted KAs in the Baltimore-
Washington Metropolitan area. The ﬁrst study, from here on
referred to as Study 1, entitled “Self-help Intervention Program for
HBP care (SHIP-HBP)” was conducted with middle-aged KAs
(N ¼ 445). The enrollment period for Study 1 was conducted from
October 2003 to December 2004. Eligibility criteria included: (a)
self-identiﬁcation as a ﬁrst-generation KAs, (b) 40e64 years of age,
and (c) systolic BP (SBP)  140 and/or diastolic BP (DBP) 90 mm
Hg or taking BP medication. Study brochures and ﬂyers were
distributed at ethnic churches, grocery stores, and social clubs in
the KA community. Additionally, intensive media campaigns
announcing the project were made through ethnic newspapers,
weekly magazines, and several ethnic radio stations. Detailed
procedures regarding the outreach and recruitment have been
published elsewhere (Han et al., 2007). In this analysis, we included
data from 185 KAs (range: 40e64 yr, M  SD: 52.5  5.42 yr) who
completed the HBMA-K questionnaire.
The second study, from here on referred to as Study 2, came
from a prospective intervention trial for HBP control designed totest the effects of a health literacy-focused behavioral intervention
with hypertensive KA immigrants over 60 years of age (N ¼ 440).
The enrollment period for Study 2 was conducted from January
2008 to May 2009. Inclusion criteria were as follows: (a) being able
to read and speak Korean, (b) being on antihypertensive medica-
tion, and (c) having no cognitive impairment, screened through the
Mini-Mental State Examination. Participants were recruited from
ethnic churches in the target regionwith intensive outreach efforts
during weekends. For this analysis, data from 340 elderly KAs
(range: 60e89 yr, M  SD: 70.88  5.39 yr) were used. Together,
a combined total of 525 KAs with HBP were included in the analysis
Procedures
To conduct the instrument validation study, the HBMA-K scale
was translated into Korean by bilingual researchers, then back
translatedbyotherbilingual researchersandﬁnallycross-checkedby
all translators. There were no reported problems in understanding
the scale, nor was cultural rewording necessary. Data on demo-
graphic and psychological variables, as well as antihypertensive
medication usage were all obtained via participant self-report using
a face-to-face interview method conducted by trained bilingual
research staff. During thebaseline evaluation for Study1 andStudy2,
the trained bilingual research staff also measured BP. Additionally,
trained bilingual research staff, some of whom were nurses, were
available at all recruitment events held in the community to ensure
completeness of the surveys and to answer any questions that
participants had. Surveys were conducted using a structured data
collection questionnaire. The Johns Hopkins University Institutional
Review Board approved all the study procedures and all the partici-
pants provided written informed consent prior to the interview.
Measurements
The study questionnaire included questions about demographic
characteristics (gender, age, years of education, marital status, and
working status). Additionally, medical history (duration of HBP,
comorbidity, primary care provider [PCP] usage, health insurance
status, years of HBP treatment, and BP) was collected.
Blood pressure
Participants’ BP was measured by a trained research staff using
the A&D UA-767 (A&D Company, Ltd, Tokyo, Japan). This device has
been validated against a mercury sphygmomanometer. Participants
were seated quietly for at least 5 minutes in a chair, with their feet
on the ﬂoor and arms supported at heart level. Caffeine intake,
exercise, and smoking were avoided for at least 30 minutes prior to
the measurement. An appropriately-sized cuff was used and
measurements were averaged using the second and third BP
readings, recorded in mmHg. In accordance with the deﬁnition
used in the seventh report of the Joint National Committee on the
Prevention, Detection, and Treatment and Control of High Blood
Pressure, BP control was deﬁned as BP < 140/90 mmHg (<130/
80 mmHg for patients with diabetes) (National Heart, Lung and
Blood Institute [NHLBI], 2004).
Korean version of the HBMA subscale (HBMA-K)
The original Hill-Bone scale consists of 14 four-point Likert-type
items (1 ¼ none of time, 2 ¼ some of the time, 3 ¼ most of time, and
4¼ all the time) with three underlying domains: medication taking,
appointment keeping, and salt intake. While the medication
subscale has been proven to be signiﬁcantly associated with blood
pressure control, the other subscales have shown consistently low
validity and internal reliability in previous studies (Karademir et al.,
2009; Krousel-Wood et al., 2005; Lambert et al., 2006). In the
Table 1
Demographic Characteristics of Each Study.
Characteristics Total
(N ¼ 525)
Study 1
(n ¼ 155)
Study 2
(n ¼ 370)
Frequency (%)
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for KAs with HBP. For this purpose, we selected the 9-item medi-
cation taking subscale and translated them into Korean. The total
scores on this subscale range from 9 to 36 with higher scores
reﬂecting poorer adherence to antihypertensive drug therapy.Female 349 (66.5) 88 (56.8) 261 (70.5)
Married 362 (69.0) 144 (92.9) 218 (58.9)
Employed full or part-time 373 (71.0) 125 (80.6) 248 (67.0)
Health insurance 373 (71.0) 63 (40.6) 310 (83.8)
Comorbiditya 230 (43.8) 49 (31.6) 181 (48.9)
Having PCP 476 (90.7) 128 (82.6) 338 (94.1)
Controlled BPb 227 (43.2) 64 (41.3) 163 (44.1)
M (SD)
Age, yr 65.5 (10.0) 52.54 (5.4) 70.88 (5.4)
Education, yr 11.83 (4.1) 13.52 (2.6) 11.12 (4.4)
Duration of having HBP, yr 9.34 (8.4) 5.78 (6.1) 10.94 (8.8)
Note. BP¼ blood pressure; HBP¼ high blood pressure; PCP¼ primary care provider.
a Comorbidity includes diabetes, coronary heart failure, kidney disease and angina
pectoris; b Controlled BP: Deﬁned as BP < 140/90 mmHg (130/85 mmHg for
patients with diabetes).Knowledge and belief related to HBP management
HBP knowledge was assessed using a 26-item test (E. Y. Kim
et al., 2007; Lee et al., 2010). Potential scores on the HBP knowl-
edge test range from 0 to 26, with higher scores indicating greater
HBP knowledge. E. Y. Kim et al. reported that the scores on the
HBP knowledge test had a signiﬁcantly negative correlation with
medication adherence. The internal consistency of the HBP
knowledge items, measured by Kuder-Richardson (KR)-20 coefﬁ-
cient, was .77, based on a previous study (Lee et al., 2010). The
KR-20 coefﬁcient for this study was .61 for the combined samples.
Beliefs about HBP weremeasured by a Hypertension Belief Scale
(Bloomﬁeld, Young, & Graves, 1993). It assesses how important
individuals perceived HBP management to be for their health, with
particular regards to smoking, stress, weight, alcohol, salt, antihy-
pertensive regimens, coffee, diet, cholesterol, overwork and exer-
cise. The HBP belief scale was translated into Korean, and used on
middle-aged KAs with HBP (M. T. Kim et al., 2008; Lee et al.,
2010). The scale consists of 11 items, assessed on a 4-point Likert
scale, ranging from 1, which indicated not at all to 4, which indi-
cated very important. Possible scores range from 11 to 44, with
higher scores representing higher levels of positive HBP beliefs. In
a study by M. T. Kim et al. (2008), scores on this scale were posi-
tively correlated with BP control, and demonstrated a Cronbach’s
alpha of .89. The Cronbach’s alpha for this study was .76.Table 2
Proportion of Participants Who Responded None of the Time to HBMA-K Scale.
Itemsa Frequency (%)
How often do you. Total
(N ¼ 525)
Study 1
(n ¼ 155)
Study 2
(n ¼ 370)
1. Forget to take your hypertension
medicine?
337 (64.2) 89 (57.4) 248 (67.0)
2. Decide not to take your
hypertension medicine?
425 (81.0) 108 (69.7) 317 (85.7)
3. Forget to get prescriptions ﬁlled? 482 (91.8) 133 (85.8) 349 (94.3)
4. Run out of hypertension pills? 453 (86.3) 119 (76.8) 334 (90.3)
5. Skip your hypertension medicine
before you go to the doctor?
431 (82.1) 118 (76.1) 313 (84.6)
6. Miss taking your hypertension
pills when you feel better?
440 (83.8) 110 (71.0) 330 (89.2)
7. Miss taking your hypertension
pills when you feel sick?
475 (90.5) 127 (81.9) 348 (94.1)
8. Take someone else’s
hypertension pills?
512 (97.5) 148 (95.5) 364 (98.4)
9. Miss taking your hypertension pills
when you are careless?
338 (64.4) 88 (56.8) 250 (67.6)
No. of adherenceb 229 (43.6) 61 (39.4) 168 (45.4)
Note. HBMA-K ¼ Hill-Bone Medication Adherence Korean version.
a Each item can be answered on a 4-point Likert-scale (1¼ none of the time, 2¼ some
of the time, 3 ¼ most of the time, and 4 ¼ all the time); b Number of participants who
answered none of the time for all 9 items.Data analysis
Psychometric testingwas conducted in three steps. The ﬁrst step
involved assessing the frequency and distribution of each item on
the scale. Participants’ demographic characteristics as well as
individual items on the HBMA-K scale were summarized using
descriptive statistics. The next step consisted of assessing the
internal consistency reliability, corrected item-total correlation,
and inter-item correlation. Speciﬁcally, the internal consistency of
the HBMA-K scale was assessed using the Cronbach’s alpha . Item
analysis was then performed to see if any items showed inter-item
correlations below or above the desired criteria (>.30 or <.70)
across the entire sample (Nunnally & Bernstein, 1994). Item-total
correlations were determined after item correction, with the
desired criteria set at >.30 (Nunnally & Bernstein). Finally, explor-
atory factor analysis (EFA) as well as testing theoretically driven
hypothesis were used to test construct validity. In EFA, the initial
factor selection was based on both empirical criterion (Eigen
value > 1 tenant) and theoretical guidance (interpretability of the
factors). Concurrent validity indicates the extent to which a score
on a scale is correlated with some criterion measure (Waltz,
Strickland, & Lenz, 2010). Based on the existing literature (Lee
et al., 2010; Martin, Prayor-Patterson, Kratt, Kim, & Person, 2007),
the present study assessed how well theoretically related variables
for chronic disease management (i.e., BP, HBP knowledge and belief
in HBP management) were correlated with medication adherence.
To further support the testing of these relationships, the Hill-Bone
adherence scale has been associatedwith clinical outcomes, such as
BP, in other translated versions (M. T. Kim, Kim, et al., 2000;
Lambert et al., 2006). All analyses were completed using SPSS
statistical software program (SPSS Inc., Chicago, IL, USA) and carried
out at a signiﬁcance level of .05.Results
Sample characteristics
Given that the overall sample of KA hypertensive participants
came from two studies designed for different study aims, the
demographic characteristics of the two studies varied slightly. As
such, they are presented separately to highlight the added repre-
sentativeness that is gained from combining the two samples. The
demographic characteristics of the combined sample (N ¼ 525) are
also presented in Table 1. The combined data set was used to assess
the validity and reliability of the HBMA-K scale.
Participants from Study 1 were younger (52.5  5.4 yr vs.
70.9  5.4 yr) and more educated (13.5  2.6 yr vs. 11.1  4.4 yr),
but less likely to have health insurance compared to those from
Study 2. BP control rates were 41.3% and 44.1% for Studies 1 and 2,
respectively.
The number of participants reporting medication adherence
(i.e., those who answered none of the time for all 9 items) in Studies
Table 3
Factor Analysis and Corrected Item Total Correlation.
Items Model l Model 2
How often do you. Factor 1 Factor 1
Eigen value 2.81 2.83
Percantage of variance 31.26 35.39
1. Forget to take your hypertension medicine? 0.64 0.60
2. Decide not to take your hypertension medicine? 0.48 0.50
3. Forget to get prescriptions ﬁlled? 0.57 0.59
4. Run out of hypertension pills? 0.64 0.62
5. Skip your hypertension medicine before
you go to the doctor?
0.40 0.42
6. Miss taking your hypertension pills
when you feel better?
0.70 0.73
7. Miss taking your hypertension pills
when you feel sick?
0.63 0.66
8. Take someone else’s hypertension pills? 0.10 e
9 Miss taking your hypertension pills
when you are careless?
0.62 0.60
Cronbach’s alpha .77 .80
Range of corrected item-total correlation .09e.61 .37e.63
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“How often do you take someone else’s hypertensive pills” had the
highest proportion of respondents who answered none of time
(97.5%). The item, “How often do youmiss taking your hypertensive
pills when you are careless” had the lowest proportion of respon-
dents who answered none of time (56.8%) in Study 1. In Study 2, the
item “How often do you forget to take medicine” had the lowest
proportion of respondents who answered none of time (67.0%).
Construct validity
EFA revealed that a one-factor solution was the best way to
characterize the data. The factor loadings on eight of the nine items
were all above .40, and corresponded to a single latent factor
named “medication adherence”. The one item that did not load
onto that factor was, “How often do you take someone else’s
hypertension pills?” It revealed a relatively weak loading of .10.
Using the eight items, the one-factor solution explained 35.4% of
the variance in medication adherence (Table 3).
Concurrent validity
We analyzed the correlations between HBP knowledge, HBP
belief and BP outcomes with the 8-item HBMA-K scale to assess
concurrent validity (Table 4). While recalling that higher HBMA-K
scores represent lower medication adherence, the mean HBMA-K
score showed a signiﬁcant positive correlation with SBP and DBP,
and negative correlation with knowledge and HBP belief score in
the combined sample.
Internal consistency
Cronbach’s alpha of the HBMA-K scale with nine items was .77
(Table 3). The corrected item-total correlation of the item “HowTable 4
Correlation Between HBMA-K and Theoretically Related Variables.
Variables Systolic BP Diastolic BP HBP knowledge HBP belief
HBMA-Ka r ¼ .18* r ¼ .24* r ¼ e.13* r ¼ e.18*
Note. BP ¼ blood pressure; HBP ¼ high blood pressure; HBMA-K ¼ Hill-Bone
Medication Adherence Korean version.
a The higher HBMA-K score, the lower adherence to medication taking; HBMA-K is
modiﬁed model with 8 items.
*p < .01.often do you take someone else’s hypertension pills?” was .09. The
consistently low performance of this item points to potential
measurement error that could be due to a possible “social desir-
ability bias” in that people may not want to report talking someone
else’s medication. In Model 2 this item was deleted and the recal-
culated Cronbach’s alpha improved to .80 (Table 3). This conﬁrmed
our initial suspicion about the signiﬁcant inclusion of measurement
error in that item. The corrected item-total correlations in Model 2
ranged from .37 to .63.
Discussion
The psychometric assessment and its ﬁndings in this study
support the validity and reliability of an 8-item HBMA-K scale. We
found that scores on the HBMA-K with eight items were predictive
of BP outcomes and were signiﬁcantly correlated with other
theoretically selected variables. The ﬁndings are consistent with
those of previous studies (Karademir et al., 2009; M. T. Kim, Hill,
et al., 2000; Krousel-Wood et al., 2005; Lambert et al., 2006).
The reliability of the 8-item HBMA-K scale was also acceptable
(Cronbach’s alpha¼ .80). Validation studies of the Hill-Bone scale in
other languages have revealed comparable reliability coefﬁcients
(Karademir et al., 2009; Koschack et al., 2009; Lambert et al., 2006).
For example, Karademir et al. reported that the Turkish version of
the Hill-Bone scale with nine items had a Cronbach’s alpha of .72.
Similarly, Lambert et al. also published a South African version of
the scale with a Cronbach’s alpha of .77.
The result of our EFA, which yielded a one-factor model, is also
consistent with previous validation studies that looked speciﬁcally
at the medication subscale of the Hill-Bone scale (M. T. Kim, Hill,
et al., 2000; Krousel-Wood et al., 2005). The proportion of vari-
ance explained by the one-factor solution was higher among the
middle-aged KA sample than the senior KA sample. This ﬁnding
implies that the HBMA-K may be a better predictor of medication
adherence among middle-aged KAs rather than older KAs.
In our study, one item did not perform well, “How often do you
take someone else’s hypertension pill?” The low performance of
this item may potentially be related to a “social desirability bias”.
While some of our previous data (E. Y. Kim et al., 2007; M. T. Kim
et al., 2001) suggests that “sharing BP medications with others is
a relatively common practice,” many participants also know that it
is not “socially desirable,” to report doing so to health care
providers. That itemwas also identiﬁed as questionable in previous
studies with other racial and ethnic groups (Karademir et al., 2009;
Koschack et al., 2009; Krousel-Wood et al., 2005; Lambert et al.,
2006).
In this study, we did not include the problematic item in the
ﬁnal model. However, careful consideration of the item with
regard to its importance and how its delivery may or may not
create error should be given before an item is discarded. Dong
Byung Sang Lyundif someone has the same disease as another
person, they feel sympathy for each otherdis a commonly shared
cultural theme among KAs that affect their health practices. This
cultural attitude may result in unsafe health behaviors such as
sharing medications or pills. It is critical to investigate whether
individuals are “sharing” medication so that we can develop
individualized interventions based on their health beliefs, as
well as help categorize medication adherence risk behavior (i.e.,
intentional vs. nonintentional nonadherence).
One strategy to approach this kind of sensitive question, while
maximizing the probability of an authentic response, is to assure
participants that this practice is often observed among their peers.
This may help them feel that they are not being critically judged
based on their behavior. For example, studies wishing to identify
illicit drug use on certain populations often start questions with the
Y. Song et al. / Asian Nursing Research 5 (2011) 183e188 187following introductory phrase: “In our community, many people
often use illicit drugs. We were wondering how many times you
have used an illicit drug over the last week?” The addition of
a simple introductory phrase has been shown to reduce social
desirability bias and improve the authenticity of responses signif-
icantly (M. T. Kim & Hill, 2003). However, since an introductory
phrase was not used on our problematic item, the potential
measurement error that ensued precluded our ability to justify its
inclusion into the ﬁnal scale. Additional testing of this important
item with improved strategy is necessary in addressing potential
cultural norms or behaviors that may affect their medication taking
behavior in the KA community .
This study has some limitations. First, patient adherence to
medication was self-reported. Although adherence to HBP medi-
cation can be assessed using various methods such as medication
event monitoring systems, drug level measurement in the body, or
reﬁll compliance calculations from claims data (Kripalani, Risser,
Gatti, & Jacobson, 2009), patient’s self-report has been recom-
mended as one of the most practical and cost effective methods
especially for ethnic minorities such as KAs (Osterberg & Blaschke,
2005). Second, two independent data sets were used in this study
to create a larger sample size to test the validity and reliability of
the instrument. While larger sample sizes offer better opportuni-
ties to test the instruments, the data set might inadvertently
include potential bias that inﬂuence the distribution of certain
items on the scale. For example, the two samples have different
distributions of demographic factors such as “access to care and
medication”, which may be due to age-based medical entitlement
programs in the US. This in turn may decrease the variability in
responses to items within each sample. Third, a relatively weak
correlation between the HBMA-K scale and BP outcomes calls for
additional evaluation as well as innovative strategies to improve
the clinical utility of the instrument. Nevertheless, the weak
correlation may speak to the multidimensional nature of the
construct. Additional conceptual analysis is warranted to capture
the unique underlying medication taking behavior of different
cultural groups to elucidate this complex phenomenon. Fourth, the
HBMA-K scale does not provide a cutoff point as compared to the
Morisky scale (Morisky et al., 2008). Systematically identifying
a cutoff point for the HBMA-K scale may help predict clinical
outcomes such as BP, for which additional research is warranted.
Lastly, according to the Joint National Committee (JNC) VII guide-
lines, several evidence-based recommendations for the control of
HBP were made, including reducing weight, adopting a dietary
approach to stop hypertension, reducing dietary sodium intake,
engaging in physical activities, moderating alcohol intake and
adhering to medication (NHLBI, 2004). The present study only
focuses on validating one aspect of BP control among KA pop-
ulations. Further studies are needed to develop and test
measurement tools that can capture the multidimensional
behaviors related to BP control. The 8-item HBMA-K scale can
serve as a useful starting point for developing such a tool.
Conclusion
The prevalence and control of HBP differ across racial and ethnic
groups in the US population (NHLBI, 2004). For KAs, an emerging
ethnic minority group, health disparity in the prevalence and
control of hypertension has been well documented (Han et al.,
2007; E. Y. Kim et al., 2007). The present study provides empirical
support for an evaluation tool that assesses antihypertensive
medication adherence, a key factor that must be addressed for
successful control of HBP, in this high-risk population. Health care
providers and researchers can use the information to better
understand their patients’ degree of medication adherence, andthen establish tailored strategies for improving adherence in KAs
populations with HBP.
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